ArticleCancer2009
Long-term incidence of cervical cancer in women with human immunodeficiency virus.
Article in Cancer, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
30 citing papers in PubMed.
- Negative predictive value of pap testing: implications for screening intervals for women with human immunodeficiency virus.Obstetrics and gynecology · 2012Trial
- Article
- HIV-1-Mediated Acceleration of Oncovirus-Related Non-AIDS-Defining Cancers.Biomedicines · 2022Review
- Veteran Women Living With Human Immunodeficiency Virus Have Increased Risk of Human Papillomavirus (HPV)-Associated Genital Tract Cancers.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021Article
- HPV vaccination of immunocompromised hosts.Papillomavirus research (Amsterdam, Netherlands) · 2017Article
- Cervical cancer incidence after up to 20 years of observation among women with HIV.International journal of cancer · 2017Observational
- Cervical cancer control in HIV-infected women: Past, present and future.Gynecologic oncology reports · 2017Review
- Cervical cancer screening intervals and management for women living with HIV: a risk benchmarking approach.AIDS (London, England) · 2017Article
- Screening for Cancer in Persons Living with HIV Infection.Trends in cancer · 2016Review
- Association of cervical precancer with human papillomavirus types other than 16 among HIV co-infected women.American journal of obstetrics and gynecology · 2016Article
- Human papillomavirus vaccination in HIV-infected women: need for increased coverage.Expert review of vaccines · 2016Review
- Incidence of cervical precancers among HIV-seropositive women.American journal of obstetrics and gynecology · 2015Article
- Changes in knowledge of cervical cancer following introduction of human papillomavirus vaccine among women at high risk for cervical cancer.Gynecologic oncology reports · 2015Article
- Structural and sociocultural factors associated with cervical cancer screening among HIV-infected African American women in Alabama.AIDS patient care and STDs · 2015Article
- HIV and cancer: a comparative retrospective study of Brazilian and U.S. clinical cohorts.Infectious agents and cancer · 2015Article
- Long-term cumulative detection of human papillomavirus among HIV seropositive women.AIDS (London, England) · 2014Observational
- Long-term cumulative incidence of cervical intraepithelial neoplasia grade 3 or worse after abnormal cytology: impact of HIV infection.International journal of cancer · 2014Article
- Knowledge, awareness and attitudes about cervical cancer among women attending or not an HIV treatment center in Lao PDR.BMC cancer · 2014Article
- Malignancies in HIV/AIDS patients attending an outpatient clinic in Vitória, State of Espírito Santo, Brazil.Revista da Sociedade Brasileira de Medicina Tropical · 2012Article
- Prevalence and risk factors for HPV in HIV-positive young women receiving their first HPV vaccination.Journal of acquired immune deficiency syndromes (1999) · 2012Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundThe objective of this study was to estimate the incidence of invasive cervical cancer (ICC) in women with human immunodeficiency virus (HIV) and compare it with the incidence in HIV-uninfected women.
methodsIn a cohort study of HIV-infected and uninfected women who had Papanicolaou tests obtained every 6 months, pathology reports were retrieved for women who had biopsy results or a self-report of ICC. Histology was reviewed when reports confirmed ICC. Incidence rates were calculated and compared with those in HIV-negative women.
resultsAfter a median follow-up of 10.3 years, 3 ICCs were confirmed in HIV-seropositive women, and none were confirmed in HIV-seronegative women. The ICC incidence rate was not found to be associated significantly with HIV status (HIV-negative women [0 of 100,000 person-years] vs HIV-positive women [21.4 of 100,000 person-years]; P = .59). A calculated incidence rate ratio standardized to expected results from the Surveillance Epidemiology and End Results database that was restricted to HIV-infected Women's Interagency HIV Study participants was 1.32 (95% confidence interval, 0.27-3.85; P = 0.80).
conclusionsAmong women with HIV in a prospective study that incorporated cervical cancer prevention measures, the incidence of ICC was not significantly higher than that in a comparison group of HIV-negative women.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.